# Quaker Chemical share price today (Quaker Chemical Corporation, KWR)

> Quaker Chemical Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. KWR · Materials · Specialty Chemicals · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/kwr

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: $149.59 (+7.7% in a year)
- P/E: 26.7× (lower than 64% of the last 4.6 years)
- Revenue (Jun 2026): $533 M (+10.2% on a year ago)
- Profit (Jun 2026): $26.7 M
- Operating margin: 9.1% (−1.6 points on a year ago)
- ROE: 0%, FY25
- ROIC: 6.5%, against a 9.6% cost of capital: −3.1 points

The main question: the share price moved +7.7% in a year while yearly earnings per share moved −102.2%. The difference came from the market paying a higher multiple. ## What is the Quaker Chemical share price today? Quaker Chemical Corporation's share price was $149.59 at the close on 3 November 2026. It has been moving sideways for 1 week. That is 0.4% below its average price over the last 200 trading days. In the last 52 weeks it traded between $115 and $179, and at that close it sat 54% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 2 weeks running. Over the last 10 years the share price moved +66% while the S&P 500 moved +255%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 23 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Quaker Chemical pay? Quaker Chemical Corporation paid $2.04 per share over the last four reported quarters. The most recent declaration was $0.51 for Jun 2026. At today's price of $149.59 that is a yield of 1.36%, based on dividends already paid, not a forecast. ## Which stock lists is Quaker Chemical on? Quaker Chemical is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Quaker Chemical profitable? Quaker Chemical Corporation earned $26.7 M of net profit in the Jun 2026 quarter. The full FY25 year was a loss of $2.5 M. That is 5.0% of the quarter's revenue. The same quarter a year earlier lost $66.5 M. 1 of the last 12 reported quarters were loss-making. For the full year, FY25 profit was −$2.5 M (−102.1% on the year before). On average over the last four quarters, profit changed +31.1% and revenue +7.8%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit. ## How much revenue does Quaker Chemical make, and is it growing? Quaker Chemical Corporation reported $533 M of revenue in the Jun 2026 quarter, +10.2% on the same quarter a year earlier. That is the 5th quarter in a row with growth on the year before. Over 4 years it has grown 1.8% a year on average. The last full year, FY25, came in at $1.9 B. The last four reported quarters add to $2.0 B. FY25 revenue was $1.9 B, +2.7% on the year before. Recent pace: the last four quarters grew +7.8% on average, against 1.8% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +7.8%, against +2.2% a year over the last 8 quarters (accelerating). ## How much of every $100 of sales does Quaker Chemical keep? Quaker Chemical Corporation's operating margin was 9.1% in the Jun 2026 quarter, 1.6 percentage points lower than the same quarter a year ago. Across 5 years it has been between 7.7% and 11.3%. The latest quarter is within that range. Why the margin moved: operating margin changed −1.6 percentage points on the year while gross margin changed −1.3 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Quaker Chemical's profit turning into cash? Over the last 3 years, 152% of Quaker Chemical Corporation's reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $136 M of operating cash against −$2.5 M of profit. After $55.9 M of spending on assets, $80.6 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Quaker Chemical's cash go? Quaker Chemical Corporation does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $136 M on assets over the last 3 years. Averaged over those years that is 2.4% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $136 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Quaker Chemical's P/E ratio, and how does it compare with its own history? Quaker Chemical Corporation's P/E is 26.7×, in the middle of its own history: higher than 36% of past readings. Its usual P/E (the middle reading) is 29.0×, over 4.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −102.2% while the price moved +7.7%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 3 years the price moved −2.5% a year; about +83.8% a year came from earnings growth and about −86.3 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Quaker Chemical business getting better or worse? Quaker Chemical Corporation's business is getting worse. Profit and EPS growth are shrinking: profit growth is −95.4% in the latest quarter, against +1316.0% at its best in 12 quarters, with ROCE steady at 7.6%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## How much does Quaker Chemical earn on its capital? Quaker Chemical Corporation earned a ROE of 0% in FY25. That is up from a low of −1% in FY22. Its return on capital used (ROIC) is 3.1 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −0.1% net margin and 0.68× asset turnover (sales divided by assets). Why the return is what it is (FY25): a −0.1% net margin × 0.68× asset turnover × 2.03× leverage (assets divided by equity) ≈ −0.1% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 6.5% − 9.6% = −3.1 percentage points. The 9.6% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The 6.5% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at −1.0%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Quaker Chemical have too much debt? Quaker Chemical Corporation has total debt of $924 M against shareholder equity of $1.4 B as of Jun 2026, so its debt is 0.67× its equity. Year by year, that ratio went from 0.67 in FY21 to 0.66 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Quaker Chemical shareholding pattern? 12.9% of Quaker Chemical Corporation's tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 12.3 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Quaker Chemical from balance-sheet trouble? For Quaker Chemical Corporation, the Z-score is 2.49. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 2.49 is in the grey area, neither clearly safe nor clearly in trouble. ## How does Quaker Chemical rank in its industry? 37.4 out of 100, rank 27 of 29 in Specialty Chemicals, with 64% of the evidence available. Quaker Chemical Corporation scores 37.4 out of 100 against the 29 companies it is compared with in Specialty Chemicals, ranking 27. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 15.1 + 7.9 + 10.1 + 4.3 = 37.4. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Quaker Chemical compared with? Quaker Chemical ranks 27 of 29 Specialty Chemicals companies on the 4-Factor Sector Score, with 37.4 out of 100. 1. [Ingevity Corporation](https://www.sectoralpha.in/us/stocks/ngvt) NGVT · quiet · Most evidence points up · 66% evidence 65.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.1/35 · Revenue n/a · Profit n/a · Operating margin change 6.6 points · 39% evidence Capital efficiency 18.8/25 · ROCE 23.7% · Operating margin 29.9% · 76% evidence Valuation 13.1/20 · P/E 48.1× · PEG 0.44 · 65% evidence Relative strength 11.2/20 · Lead over its industry 1.2% · Lead over S&P 500 2.1% · 1 year 52.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 22.1 + 18.8 + 13.1 + 11.2 = 65.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Sociedad Química y Minera de Chile S.A.](https://www.sectoralpha.in/us/stocks/sqm) SQM · quiet · Evidence leans up · 81% evidence 64.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 31.2/35 · Revenue 59% · Profit 100% · Operating margin change 32.2 points · 83% evidence Capital efficiency 18.5/25 · ROCE 18.9% · Operating margin 48.8% · 76% evidence Valuation 14.2/20 · P/E 15.2× · PEG 0.81 · 65% evidence Relative strength 0.5/20 · Lead over its industry -30.8% · Lead over S&P 500 -30.1% · 1 year 10% · 100% evidence · 0 of 12 weeks ahead Exact sum: 31.2 + 18.5 + 14.2 + 0.5 = 64.4 · What this means: Earnings are strong; relative strength in its sector is -30.8% and the one-year return is 10%. 3. [Avient Corporation](https://www.sectoralpha.in/us/stocks/avnt) AVNT · quiet · Evidence leans up · 81% evidence 60.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.7/35 · Revenue 2.3% · Profit 41% · Operating margin change 1.5 points · 83% evidence Capital efficiency 8.7/25 · ROCE 7.6% · Operating margin 12.8% · 76% evidence Valuation 14.3/20 · P/E 19.9× · PEG 0.46 · 65% evidence Relative strength 15.5/20 · Lead over its industry 9.4% · Lead over S&P 500 10.6% · 1 year 45.6% · 100% evidence · 8 of 12 weeks ahead Exact sum: 21.7 + 8.7 + 14.3 + 15.5 = 60.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [PPG Industries, Inc.](https://www.sectoralpha.in/us/stocks/ppg) PPG · turning · Evidence leans up · 81% evidence 60.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.3/35 · Revenue 5% · Profit 52.2% · Operating margin change -1.2 points · 83% evidence Capital efficiency 12.4/25 · ROCE 12.6% · Operating margin 14% · 76% evidence Valuation 15.3/20 · P/E 17.2× · PEG 0.29 · 65% evidence Relative strength 15.2/20 · Lead over its industry 2.8% · Lead over S&P 500 4% · 1 year 26% · 100% evidence · 1 of 12 weeks ahead Exact sum: 17.3 + 12.4 + 15.3 + 15.2 = 60.2 · What this means: Relative strength against the index is 4%, and revenue and profit growth are weak. 5. [Balchem Corporation](https://www.sectoralpha.in/us/stocks/bcpc) BCPC · breaking out · Evidence leans up · 85% evidence 59.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.2/35 · Revenue 9.5% · Profit 14.8% · Operating margin change 1.1 points · 95% evidence Capital efficiency 16.9/25 · ROCE 14.9% · Operating margin 21.5% · 76% evidence Valuation 8.5/20 · P/E 30.8× · PEG 1.9 · 65% evidence Relative strength 11.2/20 · Lead over its industry -1.3% · Lead over S&P 500 0% · 1 year 15% · 100% evidence · 3 of 12 weeks ahead Exact sum: 23.2 + 16.9 + 8.5 + 11.2 = 59.8 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 6. [Air Products and Chemicals, Inc.](https://www.sectoralpha.in/us/stocks/apd) APD · turning · Too little evidence to rank firmly · 58% evidence 59.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.9/35 · Revenue n/a · Profit n/a · Operating margin change 1.2 points · 45% evidence Capital efficiency 11.7/25 · ROCE 8.7% · Operating margin 25.5% · 76% evidence Valuation 10.0/20 · P/E 30.7× · PEG n/a · 15% evidence Relative strength 16.9/20 · Lead over its industry 3.7% · Lead over S&P 500 4.9% · 1 year 20.5% · 100% evidence · 3 of 12 weeks ahead Exact sum: 20.9 + 11.7 + 10 + 16.9 = 59.5 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 7. [Ecolab Inc.](https://www.sectoralpha.in/us/stocks/ecl) ECL · turning · Evidence leans up · 81% evidence 56.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.8/35 · Revenue 7.1% · Profit -1% · Operating margin change -0.1 points · 83% evidence Capital efficiency 15.0/25 · ROCE 13% · Operating margin 18.5% · 76% evidence Valuation 9.9/20 · P/E 37× · PEG 1.4 · 65% evidence Relative strength 17.8/20 · Lead over its industry 4.1% · Lead over S&P 500 5.6% · 1 year 19% · 100% evidence · 4 of 12 weeks ahead Exact sum: 13.8 + 15 + 9.9 + 17.8 = 56.5 · What this means: Relative strength against the index is 5.6%, and revenue and profit growth are weak. 8. [Axalta Coating Systems Ltd.](https://www.sectoralpha.in/us/stocks/axta) AXTA · quiet · Evidence leans up · 81% evidence 55.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.6/35 · Revenue -0.9% · Profit -21.8% · Operating margin change -0.5 points · 83% evidence Capital efficiency 14.9/25 · ROCE 13.4% · Operating margin 15.2% · 76% evidence Valuation 14.6/20 · P/E 21× · PEG 0.33 · 65% evidence Relative strength 12.7/20 · Lead over its industry 2.9% · Lead over S&P 500 4.4% · 1 year 21.4% · 100% evidence · 3 of 12 weeks ahead Exact sum: 13.6 + 14.9 + 14.6 + 12.7 = 55.8 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 9. [Calumet, Inc.](https://www.sectoralpha.in/us/stocks/clmt) CLMT · leader · Evidence leans up · 64% evidence 54.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.4/35 · Revenue 12.8% · Profit n/a · Operating margin change 4.8 points · 62% evidence Capital efficiency 3.4/25 · ROCE -3.7% · Operating margin -4.6% · 76% evidence Valuation 11.4/20 · P/E -42.6× · PEG n/a · 15% evidence Relative strength 16.6/20 · Lead over its industry 28.9% · Lead over S&P 500 30% · 1 year 146.6% · 100% evidence · 12 of 12 weeks ahead Exact sum: 23.4 + 3.4 + 11.4 + 16.6 = 54.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [LyondellBasell Industries N.V.](https://www.sectoralpha.in/us/stocks/lyb) LYB · breaking out · Evidence leans up · 71% evidence 54.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.2/35 · Revenue -1.8% · Profit -238.4% · Operating margin change 13.8 points · 83% evidence Capital efficiency 10.4/25 · ROCE 8.4% · Operating margin 17.9% · 76% evidence Valuation 11.5/20 · P/E -47.3× · PEG n/a · 15% evidence Relative strength 16.5/20 · Lead over its industry 3.4% · Lead over S&P 500 4.1% · 1 year 53.6% · 100% evidence · 5 of 12 weeks ahead Exact sum: 16.2 + 10.4 + 11.5 + 16.5 = 54.6 · What this means: Relative strength against the index is 4.1%, and revenue and profit growth are weak. 11. [WD-40 Company](https://www.sectoralpha.in/us/stocks/wdfc) WDFC · quiet · Evidence leans up · 85% evidence 53.8 out of 100 Growth Capital Valuation Relative
12. [The Sherwin-Williams Company](https://www.sectoralpha.in/us/stocks/shw) SHW · basing · Evidence leans up · 81% evidence 52.7 out of 100 Growth Capital Valuation Relative
13. [RPM International Inc.](https://www.sectoralpha.in/us/stocks/rpm) RPM · basing · Evidence leans up · 85% evidence 52.0 out of 100 Growth Capital Valuation Relative
14. [Hawkins, Inc.](https://www.sectoralpha.in/us/stocks/hwkn) HWKN · turning · Evidence leans up · 81% evidence 51.4 out of 100 Growth Capital Valuation Relative
15. [Sensient Technologies Corporation](https://www.sectoralpha.in/us/stocks/sxt) SXT · losing its lead · Evidence leans up · 81% evidence 50.1 out of 100 Growth Capital Valuation Relative
16. [DuPont de Nemours, Inc.](https://www.sectoralpha.in/us/stocks/dd) DD · turning · Evidence leans down · 64% evidence 49.9 out of 100 Growth Capital Valuation Relative
17. [Linde plc](https://www.sectoralpha.in/us/stocks/lin) LIN · turning · Evidence leans down · 85% evidence 48.8 out of 100 Growth Capital Valuation Relative
18. [H.B. Fuller Company](https://www.sectoralpha.in/us/stocks/ful) FUL · quiet · Evidence leans down · 85% evidence 48.2 out of 100 Growth Capital Valuation Relative
19. [Ashland Inc.](https://www.sectoralpha.in/us/stocks/ash) ASH · quiet · Evidence leans down · 64% evidence 47.4 out of 100 Growth Capital Valuation Relative
20. [International Flavors & Fragrances Inc.](https://www.sectoralpha.in/us/stocks/iff) IFF · breaking out · Evidence leans down · 64% evidence 46.9 out of 100 Growth Capital Valuation Relative
21. [Albemarle Corporation](https://www.sectoralpha.in/us/stocks/alb) ALB · quiet · Evidence leans down · 64% evidence 43.4 out of 100 Growth Capital Valuation Relative
22. [Cabot Corporation](https://www.sectoralpha.in/us/stocks/cbt) CBT · quiet · Evidence leans down · 81% evidence 42.1 out of 100 Growth Capital Valuation Relative
23. [Element Solutions Inc](https://www.sectoralpha.in/us/stocks/esi) ESI · quiet · Evidence leans down · 85% evidence 40.9 out of 100 Growth Capital Valuation Relative
24. [NewMarket Corporation](https://www.sectoralpha.in/us/stocks/neu) NEU · quiet · Evidence leans down · 81% evidence 40.9 out of 100 Growth Capital Valuation Relative
25. [Solstice Advanced Materials, Inc.](https://www.sectoralpha.in/us/stocks/sols) SOLS · turning · Evidence leans down · 65% evidence 39.4 out of 100 Growth Capital Valuation Relative
26. [Eastman Chemical Company](https://www.sectoralpha.in/us/stocks/emn) EMN · basing · Evidence leans down · 81% evidence 38.0 out of 100 Growth Capital Valuation Relative
27. Quaker Chemical Corporation this page KWR · quiet · Evidence leans down · 64% evidence 37.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 15.1/35 · Revenue 7.8% · Profit n/a · Operating margin change -1.6 points · 62% evidence Capital efficiency 7.9/25 · ROCE 7.6% · Operating margin 9.1% · 76% evidence Valuation 10.1/20 · P/E 28.3× · PEG n/a · 15% evidence Relative strength 4.3/20 · Lead over its industry -5.2% · Lead over S&P 500 -3.9% · 1 year 8.5% · 100% evidence · 4 of 12 weeks ahead Exact sum: 15.1 + 7.9 + 10.1 + 4.3 = 37.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 28. [Westlake Corporation](https://www.sectoralpha.in/us/stocks/wlk) WLK · basing · Most evidence points down · 64% evidence 34.8 out of 100 Growth Capital Valuation Relative
29. [Perimeter Solutions, Inc.](https://www.sectoralpha.in/us/stocks/prm) PRM · quiet · Most evidence points down · 64% evidence 29.3 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Specialty Chemicals](https://www.sectoralpha.in/us/sectors/specialty-chemicals), all 29 compared on one page. ## Which companies are close to Quaker Chemical in size? Quaker Chemical is the 29th largest of 47 Specialty Chemicals companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Hawkins, Inc., WD-40 Company and H.B. Fuller Company. Just below it: Ingevity Corporation, Innospec Inc. and Minerals Technologies Inc. ### Specialty Chemicals companies close in size

1. [Hawkins, Inc.](https://www.sectoralpha.in/us/stocks/hwkn) $3.2 billion
2. [WD-40 Company](https://www.sectoralpha.in/us/stocks/wdfc) $3 billion
3. [H.B. Fuller Company](https://www.sectoralpha.in/us/stocks/ful) $2.7 billion
4. Quaker Chemical Corporation $2.6 billion
5. [Ingevity Corporation](https://www.sectoralpha.in/us/stocks/ngvt) $2.5 billion
6. [Innospec Inc.](https://www.sectoralpha.in/us/stocks/iosp) $2.4 billion
7. [Minerals Technologies Inc.](https://www.sectoralpha.in/us/stocks/mtx) $2 billion

[All 47 Specialty Chemicals companies, largest first](https://www.sectoralpha.in/us/sectors/specialty-chemicals#all-companies)

### Companies close in size in other industries

1. [Four Corners Property Trust, Inc.](https://www.sectoralpha.in/us/stocks/fcpt) $2.5 billion · REIT - Retail
2. [PHINIA Inc.](https://www.sectoralpha.in/us/stocks/phin) $2.5 billion · Auto Parts
3. Quaker Chemical Corporation $2.5 billion
4. [Newell Brands Inc.](https://www.sectoralpha.in/us/stocks/nwl) $2.5 billion · Household & Personal Products
5. [Cadeler A/S](https://www.sectoralpha.in/us/stocks/cdlr) $2.5 billion · Engineering & Construction

## What else do people ask about Quaker Chemical? ### What were Quaker Chemical's latest quarterly results? Quaker Chemical Corporation reported revenue of $533 M and net profit of $26.7 M for the Jun 2026 quarter. Earnings per share were $1.55. The operating margin was 9.1%, 1.6 percentage points lower than a year earlier (as of 3 November 2026). ### What is Quaker Chemical's market cap? Quaker Chemical Corporation's market capitalisation is $2.6 B at a stock price of $149.59. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Quaker Chemical performing? Quaker Chemical Corporation's share price has been moving sideways for 1 weeks. Over the past 13 weeks it has done worse than the S&P 500, for 2 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Quaker Chemical's stock price go up? This page does not forecast Quaker Chemical Corporation's stock price. What it shows instead: the stock price is $149.59, and it has been moving sideways for 1 weeks. Its P/E of 26.7× is higher than 36% of its own last 5 years (as of 3 November 2026). ### Is Quaker Chemical's profit real cash? Yes, over the last 3 years, 152% of Quaker Chemical Corporation's reported profit came in as cash from operations. The latest year was lower at -5529%, so the trend is worth watching. In FY25, operating cash was $136 M against reported profit of −$2.5 M. Most of that cash then goes into building new capacity. These are yearly figures (as of 3 November 2026). ### Where is Quaker Chemical in its business cycle? Quaker Chemical Corporation's FY25 operating margin was 10.2%, against a 5-year range of 7.7% to 11.3%: the middle of its own range, neither a peak nor a low. The latest quarter was 9.1%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Quaker Chemical story? The main question: the share price moved +7.7% in a year while yearly earnings per share moved −102.2%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Quaker Chemical a stock worth studying right now? What the numbers show: Quaker Chemical Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether earnings grow into a price that has already moved. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.